by Adrian Bradley, CEO, Arthritis and Musculoskeletal Alliance (ARMA)
As we approach publication of ARMA’s new five-year strategy, this feels like an important moment to pause and reflect on the state of musculoskeletal (MSK) health, our sector, and our Alliance.
The challenges are clear. Community MSK waiting lists remain among the longest in the NHS, leaving too many people waiting in persistent pain and unable to work, care for family, or participate fully in everyday life. In many areas, MSK health still lacks clear system leadership.…
Read more of this article

The SOMM team has developed a clear, accessible, and evidence‑informed aftercare advice leaflet to support patient safety, optimal outcomes, and integrated rehabilitation following steroid injection treatment.

Keele to lead new study to improve early diagnosis of osteoporosis

Ever wondered what happens to your blood when you give it for research?